DE69217227T2 - Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung - Google Patents

Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung

Info

Publication number
DE69217227T2
DE69217227T2 DE69217227T DE69217227T DE69217227T2 DE 69217227 T2 DE69217227 T2 DE 69217227T2 DE 69217227 T DE69217227 T DE 69217227T DE 69217227 T DE69217227 T DE 69217227T DE 69217227 T2 DE69217227 T2 DE 69217227T2
Authority
DE
Germany
Prior art keywords
dioxapyrrolomycin
antiparasitic agent
composition therefor
cestodes
trematodes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69217227T
Other languages
English (en)
Other versions
DE69217227D1 (de
Inventor
George A Conder
Ming-Shang T Kuo
Raymond J Zielinski
Vincent P Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69217227D1 publication Critical patent/DE69217227D1/de
Publication of DE69217227T2 publication Critical patent/DE69217227T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69217227T 1991-08-01 1992-08-03 Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung Expired - Fee Related DE69217227T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73976591A 1991-08-01 1991-08-01
PCT/US1992/006290 WO1993002676A1 (en) 1991-08-01 1992-08-03 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor

Publications (2)

Publication Number Publication Date
DE69217227D1 DE69217227D1 (de) 1997-03-13
DE69217227T2 true DE69217227T2 (de) 1997-06-05

Family

ID=24973695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69217227T Expired - Fee Related DE69217227T2 (de) 1991-08-01 1992-08-03 Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung

Country Status (12)

Country Link
EP (1) EP0597004B1 (de)
JP (1) JPH06509579A (de)
AT (1) ATE148342T1 (de)
AU (1) AU657357B2 (de)
CA (1) CA2112704A1 (de)
DE (1) DE69217227T2 (de)
DK (1) DK0597004T3 (de)
ES (1) ES2097921T3 (de)
GR (1) GR3022727T3 (de)
NZ (1) NZ243766A (de)
WO (1) WO1993002676A1 (de)
ZA (1) ZA925696B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58111689A (ja) * 1981-12-23 1983-07-02 Meiji Seika Kaisha Ltd 新抗生物質ピロロマイシンｅおよびその製造法

Also Published As

Publication number Publication date
DK0597004T3 (da) 1997-08-11
NZ243766A (en) 1995-04-27
EP0597004B1 (de) 1997-01-29
AU657357B2 (en) 1995-03-09
ZA925696B (en) 1994-01-31
GR3022727T3 (en) 1997-06-30
ES2097921T3 (es) 1997-04-16
AU2425392A (en) 1993-03-02
EP0597004A1 (de) 1994-05-18
CA2112704A1 (en) 1993-02-18
ATE148342T1 (de) 1997-02-15
WO1993002676A1 (en) 1993-02-18
JPH06509579A (ja) 1994-10-27
DE69217227D1 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
FI971083A (fi) Aine tuotannon lisäämiseksi eläinten kasvatuksessa ja tuotanossa siipikarjateollisuudessa
DE3777175D1 (de) Anthelmintische quaternaere alkyl-acyl-hydrazone, verfahren zur verwendung und zusammensetzungen.
NO964912L (no) Tyggbare flubendazoltabletter for selskapsdyr
PT1391155E (pt) Composicao para utilizacao em nutricao animal compreendendo uma matriz de libertacao controlada processo para prepara-la e sua utilizacao
ATE259601T1 (de) Carvacrol und thymol enthaltende zusammensetzung zur verwendung als bakterizide
NO950871L (no) For for vektökning av husdyr
EP1013288A3 (de) Verwendung von Erythropoietin zur Behandlung von Blutarmut in Vieh und in Haustiere
DE3779916T2 (de) Anthelmintische acylhydrazone, verfahren zur verwendung und zusammensetzungen.
DE3776336D1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
MX9302936A (es) Derivados de 1-[n-alquil-n-(halo-3'-piridilmetil)amino]-1-mono/dialquilamino-2-nitr oetileno para controlar pulgas en animales domesticos.
DE69217227D1 (de) Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung
SE8302283D0 (sv) Heterocykliska aminodinosubstituerade ureauforeningar och deras farmaceutiska anvendning
CA2265505A1 (en) An immune disease remedy, treatment method and preventive agent and method for dogs and cats
KR860004587A (ko) 동물 성장 자극제 조성물 및 그 제조 방법
DE69030732D1 (de) Antiparasitäre zusammensetzung zur verwendung bei tieren
DK1128737T3 (da) Anvendelse af vækstfremmende kraftfoder til dyr
GB0003234D0 (en) Method of treatment
Kassai Chemotherapeutical control of helminth infections in farm animals.
Lloyd et al. Sheep Ked Control with Amitraz Collars, Taktic® Spray, and Pour-On Applications of Taktic and Expar®, 1987
DE60229502D1 (de) Verfahren und mittel zur behandlung von krebs bei hunden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee